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HIV-1 envelope glycoproteins 
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Sara Marrero-Hernández1, Cecilia Cabrera  3, Victor Urrea  3, Concepción Casado4, 
Isabel Olivares4, Daniel Márquez-Arce1, Silvia Pérez-Yanes1, Judith Estévez-Herrera1, 
Bonaventura Clotet3,5, Lucile Espert2, Cecilio López-Galíndez4, Martine Biard-Piechaczyk2, 
Agustín Valenzuela-Fernández  1 & Julià Blanco  3,5
In untreated HIV-1-infected individuals, viremia is positively associated with disease progression. 
However, some viremic non progressors (VNPs) individuals show paradoxical high CD4+ T cell counts. 
HIV-1 envelope glycoprotein complex (Env) is a major cytopathic determinant in viral replication; 
therefore, we have deeply characterized Env function in this rare clinical phenotype. Full-length Env 
clones isolated from individuals with Viral Load (VL) > 10,000 copies/mL classified as VNPs (n = 15) 
or rapid progressors (RPs, n = 17) were geno- and phenotypically analyzed by determining diversity, 
expression, CD4 binding/signaling, fusogenicity, infectivity and autophagy induction. Selected Env 
clones from VNPs and RPs (n = 32) showed similar expression, fusion and infection abilities. Env clones 
from both groups showed similar affinity for CD4 during cell-to-cell transmission and consistently 
induced similar levels of CD4 signaling, measured by α-tubulin acetylation. Moreover, we demonstrate 
for the first time that primary Env clones from VNP and RP induce autophagy in uninfected cells and 
that this feature correlated with fusogenic capacity but was unrelated to disease progression. In 
conclusion, our data suggest that Env clones from VNP individuals are fully functional. Therefore, the 
paradoxical CD4+ T cell count stability coexisting with high levels of viral replication is unrelated to Env 
function.
Human immunodeficiency virus type 1 (HIV-1) infection destroys CD4+ T cells and compromises the function 
of the immune system leading to acquired immunodeficiency syndrome (AIDS)1,2. However, the rate of CD4+ 
T-cell depletion and the time to onset of AIDS symptoms are highly variable among HIV-1 infected individuals3. 
This variability defines several clinically relevant groups of HIV-1 infected individuals, such as long-term non 
progressors (LTNPs) that show, in general, a low viremia level (below standard detection limits in some cases) 
and a slow progression to AIDS3. The reduced level of viral replication has been associated to the magnitude and 
quality of the immune responses, in particular CD8-mediated control, which results in low or even suppressed 
viral replication4. Virological factors that impair the in vivo viral fitness have also been shown to contribute to this 
phenotype5. In an opposed setting, high levels of viral replication, either as a consequence of poor or inefficient 
immunological responses or particular viral cytopathic factors, are associated with rapid progression to AIDS6–8.
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Besides these well-characterized clinical phenotypes, in an extremely low percentage of patients, known as 
viremic non-progressors (VNPs), a high level of viral replication is accompanied by a paradoxical slow CD4+ 
T-cell destruction9. Little is known about the reasons that may explain the apparent non-cytopathic viral rep-
lication. However, it is reasonable to speculate that both immunological and virological factors are at play10. 
From an immunological point of view, VNPs do not show enhanced cytotoxic T lymphocyte (CTL) responses11 
although they seem to control exacerbated type I-interferon-mediated responses present in HIV-1 infected indi-
viduals10. This setting could be reminiscent of the non-progressive SIV infection described in sooty mangabeys 
and might maintain a relatively protected CD4 central memory subset, a key population of the CD4+ T-cell 
compartment12,13. From a virological point of view the available information is quite limited. We have previously 
described the isolation of full-length HIV-1 envelope genes (env) from a small group of VNPs9. This study showed 
that the viral tropism was R5 and that these env clones were functional regarding fusogenicity and ability to 
induce the expression of NKp44L on CD4+ T cells9. Additional available information suggest that viral replication 
capacity of viruses isolated from VNPs is impaired, whereas a maintained Nef functions has been described14,15.
Assuming the widely described major role of Env in viral fitness and pathogenesis5,16–18, we hypothesized that 
Env isolated from VNPs might have specific features leading to the VNP clinical outcome. To test this hypothesis, 
we have deeply characterized full-length Env clones isolated from VNPs by evaluating their genotypical and phe-
notypical features (CD4 binding, signaling capacity and autophagy induction). All these features were compared 
to Env isolated from RPs. Our data show that VNPs harbor fully signaling-and fusion-competent Envs, which 
also show fully cytopathic potential as assessed by their ability to induce autophagy in bystander uninfected CD4+ 
T cells.
Results
Samples and Env clones. We have previously isolated a large collection of full-length Env clones from four 
VNP and five RP individuals. Table 1 shows the main features of selected individuals. All VNP individuals showed 
plasma HIV-1 VL > 10,000 copies/mL with relatively high (>400 cells/µL) and stable levels of CD4+ T cells9. 
Patient 8 received antiretroviral therapy from 1997 to 2002, and after 2004. Plasma samples selected for this study 
belong to the period when the patient was off therapy. In contrast, individuals identified as RPs showed lower 
CD4+ T cell counts (median 358 cells/µL) with HIV-1 VL comparable to VNPs (median 95,960 copies/mL). All 
samples from this group were collected within 3 years after seroconversion (median 1 year, Table 1).
Characterization and selection of cloned env. In a previous work, we characterized the fusogenic activ-
ity of cell-surface expressed HIV-1 Envs isolated from plasma samples obtained from VNP and RP participants. A 
total of 100 clones (all showing an R5 tropism) were tested for fusogenicity in co-cultures of Tat/Env cotransfected 
HEK-293T cells and TZM-bl cells9. Figure 1A shows fusion capacity (relative to BaL) of all clones. Comparison 
of the median fusogenicity of Env isolated from each individual showed only significant differences between 
VNP11 and RP8 individuals (p = 0.03, Kruskal-Wallis test), indicating that no major difference in fusogenicity 
was evident among Envs isolated from VNPs and RPs at the individual level. Remarkably, most plasma isolated 
Envs showed higher fusogenicity than the reference BaL-Env (values > 100%).
To further characterize Env features, we genotypically analyzed the global env gene sequence collection, except 
for participant VNP10, which showed a recombinant F/B Env sequence. Consistent with longer time from sero-
conversion in VNPs (Table 1), the mean diversity of Env clones isolated from RPs was significantly lower than 
those from VNPs (p = 0.004, Mann-Whitney test, Fig. 1B). However, no significant correlation was observed 
between fusogenicity and diversity when all available participants were analyzed. Furthermore, for each clone, 
genetic distance to the patient consensus sequence was calculated; again, no correlation of genetic distances and 
fusogenicity was observed (data not shown).
Group Patient ID
Plasma VL (copies 
HIV-1 RNA/mL)
CD4+ T cell 
count (cells/µL)
Time from HIV-1 
infection (years)
VNPs
VNP8 168,193 945 7
VNP9 126,383 486 5
VNP11 25,144 995 11
VNP16 31,523 735 4
Median VNPs 78,953 840 6
RPs
RP2 226,149 180 0.8
RP6 76,965 436 1
RP7 95,960 358 1
RP8 500,000 262 2.5
RP10 53,026 359 1
Median RPs 95,960 358 1
Table 1. Main features of individuals included in the study.
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Phenotypic characterization of selected Env: expression and infectivity. Further phenotypic 
characterization of Env was performed in a selected collection of 32 Env clones (15 from VNPs and 17 from 
RPs, empty dots in Fig. 1A). The selected Env recapitulate the whole Env collection, showing similar median 
fusogenicity values and distribution (dark and light boxes for whole collection and selected Env, respectively in 
Fig. 1C).
Selected Envs were first analyzed for cell-surface expression in transfected HEK-293T cells. Similar levels of 
Env expression were observed for VNP and RP groups when mean values of selected Env from each participant 
were compared (Fig. 2A). Consistently, the means of specific fusogenicity (defined as fusion activity normalized 
by Env expression) were also similar for Env isolated from VNP or RP individuals (Fig. 2B).
Since all the above-described parameters were analyzed in a setting of cell-to-cell fusion events, we next eval-
uated Env-mediated fusion during cell-free viral infection. The infectivity of pseudoviruses bearing different Env 
was measured as infectious titers in TZM-bl cells. Mean infectivity of clones from each participant showed again 
similar values for both groups (Fig. 2C). When Envs from VNP and RP were analyzed together and considering 
multiple measures from each participant, viral infectivity was positively associated with Env expression but not 
with specific fusogenicity (Fig. 2D,E). Since, these relationships were more strongly observed in VNP Env, we per-
formed a multivariate analysis of linear mixed effect model with random intercepts to explore specific differences 
between VNP and RP Envs. This analysis showed that the only independent parameter that is associated with 
infectivity was the level of Env expression, while fusogenicity or clinical group (RP or VNP) had no significant 
impact on infectivity or fusion activity (Table 2).
CD4 binding and signaling activity of selected Envs. To further dissect potential differences among 
Envs isolated from VNP and RP individuals, we analyzed the Env attachment to CD4, by determining both the 
binding efficiency and the intracellular signals delivered into target cells. First, we assessed gp120/CD4 bind-
ing efficiency by taking advantage of the highly efficient virus binding to CD4 that occurs during virological 
Figure 1. Analysis of genotypic and phenotypic features of HIV-1 envelopes isolated from VNP and RP 
individuals. (A) Relative fusion activity of the full Env collection (BaL = 100%). Individual points correspond to 
the mean of triplicate independent experiments. Median fusogenicity of the Envs isolated from each participant 
was compared (Kruskal-Wallis test). Empty symbols, both in VNP and RP groups, indicate Envs that we select 
in this study, from the full collection of isolated Env clones (100 full-length env clones, as indicated below), to 
be further characterized in their viral functionalities. This represents a selection of 32 Envs, 15 for VNPs and 
17 for RPs. (B) Boxplot comparison of the mean diversity of the full gp160 sequence from all clones isolated 
from VNPs (n = 4, green) or RPs (n = 4, red). Comparison was performed using the Mann Whitney test. (C) 
Boxplot comparison (median and interquartile range) of relative fusion of selected env clones (n = 15 for VNPs 
and n = 17 for RPs). Statistical analysis was performed using Mann Whitney test. Data from full env collection 
(n = 36 and n = 64 for VNPs and RPs, respectively) is shown lighter on the background for comparative 
purposes.
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synapses19,20. Indeed, early HIV transfer between infected and uninfected cells is independent of coreceptor 
expression or fusion activity and is strictly dependent on the binding of gp120 to CD45. HEK-293T cells produc-
ing viral particles pseudotyped with Env isolated from VNP or RP individuals were co-cultured with primary 
human CD4+ T cells and the amounts of viruses captured by target cells was analyzed by flow cytometry19,20. In 
contrast to fusogenicity, CD4 binding capacity of primary Env was similar or lower than the reference isolates 
BaL- or NL4.3-Env (Fig. 3A). A comparison of mean Env-mediated HIV transfer calculated for each participant 
showed that Env isolated from VNPs or RPs display similar functional features (Fig. 3B).
The binding of Env to CD4 is known to trigger intracellular signals leading to a stabilization of acetylated 
α-tubulin5. To evaluate potential differences in signaling activity between VNP- or RP-Envs, pseudotyped viruses 
bearing selected Env were incubated with CEM.NKR-CCR5 cells and the level of viral infection and related 
α-tubulin acetylation were assayed. Hence, HIV-1 luciferase-reporter pseudoviruses were produced using a 
pNL4.3-Luc-R-E- vector and each of the different R5-tropic env expression clones from VNP and RP individuals, 
and an R5-tropic reference BaL strain. This technical approach, using the same viral backbone with different 
envs, allowed the generation of viral particles to infect the same permissive cells for the analysis of the functional 
involvement of each viral Env in signaling and early infection. Equal amounts of luciferase reporter pseudoviruses 
were used to infect CEM.NKR-CCR5 cells providing a quantification of HIV-1 infection in the absence of other 
viral factors and of any influence of late steps of viral infection5,21,22. We observed a heterogeneous efficiency for 
early infection in Envs isolated from either VNP or RP individuals (Fig. 3C) resulting in similar mean infectivity 
for participants from both groups (Fig. 3D). A similar scenario was observed when α-tubulin acetylation, a key 
Env/CD4-mediated signal for productive fusion and infection, as previously described5,23, was analyzed in CEM.
Figure 2. Analysis of specific fusogenicity and infectivity of selected HIV-1 envelopes isolated form VNP and 
RP individuals. Selected Env from VNPs (green) and RPs (red) were analyzed for expression after transfection 
in HEK-293T cells (panel A). The specific fusogenicity was calculated as the ratio of fusion activity and the 
number of Env cell-surface expressed molecules (panel B). Pseudoviruses bearing selected Env were tittered 
in TZM-bl cells. Titers are shown in panel C. Comparisons show mean values of selected Env from each 
participant (VNP n = 4, RP n = 5). No statistical differences were found (Mann Whitney test). Association of 
Infectivity of cell free viruses and Env expression (panel D) and fusogenicity (panel E). Green and red dots 
correspond to VNP and RP clones, respectively.
Infectivity vs Valuea Standard Error P-value
Log10 (Expression) 1.3562 0.4874 0.0055
Fusogenicity 0.0016 0.0019 0.3527
Group (VNP or RP) −0.0557 0.6683 0.9076
Table 2. Analysis of factors determining viral infectivity. Data represent the slope of multivariate linear mixed 
effect model with random intercepts. Inference was assessed through likelihood ratio test comparing the full 
model with the model without one of the predictors. A selected collection of 32 Env clones (15 of VNPs and 17 
of RPs), which correspond to empty points in Fig. 1A was used for the analysis.
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Figure 3. Analysis of CD4 binding efficiency and CD4 mediated signaling induced by selected HIV-1-Env 
isolated from VNP and RP individuals. (A) The interaction of Env with CD4 was evaluated in co-cultures of 
HEK-293T producing pseudoviruses bearing the indicated Env clones with primary CD4+ T cells. The figure 
shows Virus binding to CD4 as the % of p24+ cells assessed by flow cytometry. Panel A shows mean ± SEM 
of four different experiments for the indicated clones. Panel B shows the comparison of mean values of 
virus transfer for VNP and RP individuals. Panels C and D show Luciferase-based assay of viral infection 
in permissive CEM.NKR-CCR5 cells by non-replicative HIV-1 luciferase reporter pseudoviruses bearing 
Envs isolated form VNPs (green bars) and RPs (red bars), and control BaL.01-Env strain (gray bar). Non-
productive infection values (baseline) are obtained with a neutralizing anti-CD4 mAb (5 μg/mL), under the 
same experimental conditions. Data in panel C are mean ± SEM values of nine independent experiments 
carried out in triplicate, while panel D show global comparison of mean values of virus transfer for VNP and 
RP individuals. Panel E shows a representative quantitative western-blot analysis of Envs-induced α-tubulin 
acetylation during early infection in permissive CEM.NKR-CCR5 cells comparing VNP and RP Env. Data are 
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NKR-CCR5 cells. We observed heterogeneous ability to trigger acetylation of α-tubulin (Fig. 3E, Supplementary 
Figs 1 and 3F) by the different Envs. Although VNPs tended to trigger lower acetylation, the difference of mean 
values for each participant was not statistically significant (Fig. 3G) Taken together, these data suggest that Envs 
from VNPs or RPs showed similar CD4 binding affinity and signaling capacity.
Cytopathicity of Selected Env. Autophagy induction during cell-to-cell contacts. Finally, 
we evaluated the ability of the selected Envs to induce autophagy in uninfected CD4+ T cells. Indeed, auto-
phagy is triggered in uninfected cells after their contact with infected cells expressing Env, leading to cell 
death24–26. However, all in vitro models of autophagy induction have involved X4- and R5-tropic Envs from 
laboratory-adapted HIV-1 strains (NL4.3 and BaL, respectively). We thus evaluated the ability of primary R5 
Envs, isolated from VNP and RP individuals, to trigger autophagy in CCR5+ T cells. Co-culture of the CCR5+/
CD4+ HUT78 T-cell line with HEK-293T cells expressing primary Envs triggered the autophagy pathway in 
bystander uninfected CD4+ T cells, as measured by the number of LC3 puncta per cell after 2 days of co-culture. 
Both NL4.3- or BaL-expressing cells were used as positive controls (Fig. 4A). Although no significant difference 
between both groups was noticed (Fig. 4B), the level autophagy induction strongly correlated with the fusogenic 
activity of Env (Fig. 4C). These observations confirm the link between fusogenic function and autophagy, thereby 
suggesting that no differences in Env-mediated cytopathicity are expected among VNPs and RPs.
Discussion
Understanding viral factors associated with the VNP phenotype in HIV-1 infection may help to unveil cytopathic 
mechanisms of CD4+ T cell depletion in vivo. However, most approaches addressing potential virological and 
immunological determinants of the VNP phenotype have failed to identify a well-defined candidate. Here we 
evaluated the role of Env in the maintenance of sustained CD4+ T-cell counts in VNP individuals. Env is a key 
determinant of HIV-1 cytopathicity and its fusogenic activity has been shown to be a key determinant in CD4+ 
T cell loss, both in vitro and in vivo16,27,28. Moreover, defective specific Env functions, such as CD4 binding and 
signaling, have been recently identified in a group of LTNPs showing undetectable viremia and slow progression 
to AIDS5.
To address the role of Env in the VNP phenotype, we have analyzed a wide range of Env features. First, the 
sequence diversity was analyzed to evaluate their impact on functionality. Recently, the accumulation of genetic 
polymorphisms associated with impaired viral fitness has been described in viruses from isolated VNP individ-
uals15. Despite this observation, viral population diversity remains higher in VNPs compared to standard pro-
gressors or RPs15. Consistently, we found significant higher env gene diversity in sequences isolated from VNPs 
compared to RPs. However, the mean diversity of env sequences isolated from each individual did not correlate 
with their mean fusogenicity. Furthermore, in a single individual, the genetic distance to the patient consensus 
sequence of each clone was unrelated to its fusogenic capacity. Long-lasting coexistence of HIV-1 replication with 
host immune responses in VNPs is expected to lead to a continuous Env escape from neutralizing antibodies and 
accumulation of mutations to compensate cost in viral fitness29,30, while in RPs viral replication occurs in severely 
immunocompromised individuals favoring uncontrolled HIV-1 replication and selection of the fittest variants, 
as described for late AIDS phase of chronic infection31. In summary, our data suggest that Env plasticity allows 
for the maintenance of proper fusogenic function in both VNP and RP individuals despite representing almost 
opposite situations of HIV-1 replication.
Several authors have described that Env showing similar fusogenicity may differ in other relevant functions 
such as cell death induction16,32. Therefore, we in-depth characterized different Env functions in our clones, first 
focusing on the binding of gp120 to CD4. The interaction of Env and CD4 governs the formation of virological 
synapses20, which are involved in HIV-1 spread and in pathogenic events. Moreover, we have recently described 
a heritable default in CD4 binding and signaling as one of the mechanisms explaining the lack of progression in a 
cohort of Spanish LTNPs5. In contrast to these recent data, the binding of native Env to CD4 showed comparable 
efficiency in Envs isolated from VNPs and RPs, as measured by the efficiency of virus binding to primary CD4+ T 
cells in the context of cell-to-cell transmission. Analogously, in a cell-free virus infection model, viruses bearing 
Envs isolated from VNPs or RPs showed similar infectivity and similar ability to promote CD4-dependent signals 
(as measured by α-tubulin acetylation) in permissive CEM.NKR-CCR5 cells, ruling out an active role of a defec-
tive interaction between Env and CD4 in the VNP phenotype.
The involvement of Env in cell-to-cell HIV-1 spread is also relevant for cytopathicity. Indeed, cell-to-cell 
HIV-1 transmission is able to activate different cell death mechanisms, classically associated with apoptosis, and 
more recently, with autophagy and pyroptosis25,33,34. All of them resulting in the rapid destruction of target cells 
before being productively infected (bystander cell death)27,32. In particular, Env triggers autophagy after cellular 
contacts between Env expressing and target cells25. Autophagy occurs after gp41 activation of membrane fusion35, 
as mutations abrogating fusogenicity abolish both autophagy and cell death24. Despite the widely-described role 
represented as acetylated α-tubulin in reference to total α-tubulin (Ac. α-tub/α-tub ratios). These western-blot 
bands are key bands from full-length gels and blots presented in Supplementary Fig. 1. First, in each gel/blot, 
post-transductional acetylation of α-tubulin is detected, then membranes were gently stripped and blotted 
again to detect total α-tubulin in the same gel/blot, as described in Methods section. Therefore, acetylated 
α-tubulin and total α-tubulin and detected in the same gel/blot, under any experimental condition. Panel F 
shows histograms of the quantification of HIV-1 Env-mediated α-tubulin acetylation in permissive cells from 
three independent experiments carried out in triplicate, per each experiment condition. Data are mean ± SEM.; 
Ac. α-tub/α-tub ratios. Panel G shows comparison of mean values of virus transfer for VNP and RP individuals.
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of Env in viral cytopathicity, our data show that Env isolated from VNPs or RPs similarly trigger autophagy 
in uninfected cells. To our knowledge, this is the first report describing the ability of primary R5-tropic Envs 
to induce autophagy in uninfected CD4+ T cells. Remarkably, although the extent of autophagy induction was 
Figure 4. Analysis of the capability of selected HIV-1 Envs isolated from VNP and RP individuals to trigger 
autophagy. The ability of Env to induce autophagy in uninfected cells was evaluated by co-culturing HEK-293T 
expressing the indicated Env clones with HUT78 cells. After two days, autophagy was assessed by fluorescence 
microscopy calculating the number of LC3 puncta per cell. Panel A shows mean ± SEM of four different 
experiments for the indicated clones. Panel B shows comparison of median values between VNP and RP (green 
and red, respectively). Panel C shows the spearman correlation of autophagy induction and fusogenic activity 
for the Env evaluated. Green and red symbols correspond to VNP and RP clones respectively. Linear regression 
is also shown for illustrative purposes (black line corresponds to all data, blue and red dotted lines correspond 
to VNP and RP data, respectively).
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independent of the HIV-1+ group (VNP or RP), it strongly correlated with the fusogenic capacity of Env, sug-
gesting that autophagy induction promoted by primary isolates follows the same mechanisms described for lab-
oratory adapted Env in T cells24. The bystander effect induced by Env has been associated to specific genetic 
signatures in residues 425 and 476 of gp12032 and in residues in the HR1 sequence of gp4116. Consistent with 
the similar cytopathicity of Envs isolated from VNPs and RPs, no sequence differences in those residues were 
observed between both groups. Similarly, the N362 residue that has been associated with fusogenicity was equally 
distributed among VNP and RP groups36.
Our exhaustive analysis of Env function in VNPs has some limitations. Firstly, the analysis is limited to a 
reduced number of Env that have been carefully selected to maintain both the mean value and the heterogeneity 
of the original Env collection. Selection may introduce a bias and may also limit statistical power. Secondly, it is 
difficult to fully recapitulate in in vitro assays the functional complexity of HIV-1 Env. However, despite these 
limitations, our data suggest that Env function is comparable between VNPs and RPs and does not have a major 
role in the VNP phenotype, at least in the patients analyzed.
Other authors have explored the role of Nef in the VNP phenotype showing, as for Env, no abnormalities in 
known Nef functions14. In contrast, the in vitro replication of viruses isolated from VNP patients seems to be 
impaired as a result of the accumulation of genetic polymorphisms associated with low viral fitness15. However, 
this fact unlikely explains our data, since in vivo HIV replication is comparable in VNP and RP groups, as assessed 
by plasma VL. The lack of a clear role for viral factors in the VNP phenotype may suggest a prominent role for 
immunological factors. Interestingly, no role for CTL or neutralizing responses have been identified9,11,37; nev-
ertheless the VNP phenotype seem to be more prevalent in pediatric HIV-1 infection, suggesting that young 
immune system is more prone to coexist with high levels of viral replication10,37. Furthermore, lower CCR5 
expression and lower activation have been found in young non progressors compared to progressors37 and long 
lived central memory CD4+ T cells have been identified in pediatric and adult VNPs12,37. Such an immunological 
privilege could be eroded by efficient viral replication of functional viruses present in VNPs and these individuals 
may eventually develop AIDS when left untreated38.
The VNP phenotype in HIV-1 infection could be reminiscent to HIV-2 infection, as in many HIV-2+ indi-
viduals, disease progression occurs slowly39. In vitro studies suggest that HIV-1 and HIV-2 share similar ability 
to bind to CD4, cell tropism and viral genetic variability40,41. Moreover, both HIV-1 and -2 trigger autophagy in 
permissive infected cells, although virus-mediated autophagic cell-death mainly occurs in HIV-1 infected cells42. 
However, HIV-2 infection is commonly associated to a sustained control of viral replication43,44, thus being more 
similar to the well-defined long-term non-progression associated to natural virological control in HIV-1 infec-
tion39 than to the VNP phenotype.
In summary, our data demonstrate the lack of functional differences in Env functions (including autophagy 
induction in bystander cells) among VNP and RP individuals. Exhaustive comparative analysis of the effect of 
HIV-1 and HIV-2 replication in autophagy pathways and a better knowledge of immunological status of VNPs 
will be needed to unveil the final virological and/or immunological mechanisms underlying the VNP phenotype.
Methods
Samples and full-length Env clones. The isolation of full length Env clones from VNPs and RPs has been 
previously described9. Briefly, VNP individuals without antiretroviral therapy for at least two years (and naive 
for fusion inhibitor treatment) were identified at the Hospital Germans Trias i Pujol (Badalona, Spain). Criteria 
for VNP selection were: VL > 10,000 copies RNA/mL and levels of CD4+ T cells >400 cells/mL with a loss of 
CD4+ T cells <50 cells/mL/year. For comparative purposes, a matched group of RPs was selected from the Centro 
Sanitario Sandoval (Hospital Clínico San Carlos, IdISSC, Madrid, CAM). Rapid progression was defined by CD4+ 
T-cell levels <350 cells/mL within 3 years after seroconversion, documented by a HIV negative test within one 
year before the first positive test. A collection of 100 full-length env clones (36 from VNPs and 64 from RPs) were 
isolated and characterized9, and a smaller set of 32 clones (15 from VNPs and 17 from RPs) were further selected 
for deeper analysis. All full-length env sequences were amplified from plasma samples by standard nested PCR 
and cloned in pCDNA3.1 plasmids as described9.
Cells. The human CEM.NKR-CCR5 HIV-1-permissive cell line (Catalog No. 4376), the HEK-293T cell 
line (Catalog No. 103), the TZM-bl cell line (Catalog No. 8129) and the HUT78 cell line (Catalog No. 89) were 
from the NIH AIDS Research and Reference Reagent Program. Cells were cultured and used as previously 
described5,22,45.
Env expression and fusion assays. HEK-293T cells were co-transfected with the pTat plasmid46 and plas-
mids coding for different Env clones using CalPhos (Clontech). Of note, to avoid transfection variability, all Envs 
were co-transfected and expressed the same day for the different comparative assays performed. As a negative 
control, HEK-293T cells were transfected only with pTat. HEK-293T cells were chosen as effector cells since they 
provide sensitive measures of fusion even when using low fusogenic Env47. 24 hours post-transfection, cells were 
collected, and tested for Env surface expression and fusion activity.
To test Env expression, 2 × 105 Env/Tat co-transfected HEK-293T cells were incubated with 2G12 and IgGb12 
monoclonal antibodies (mAbs, Polymun, Viena, Austria) at 4 mg/mL each for 40 minutes at 37 °C. After washing 
the cells, the PE-labeled goat anti-human IgG (Jackson ImmunoResearch Laboratories) was added and incubated 
at room temperature for 15 minutes as described48. Cells were washed, fixed in formaldehyde 1%, acquired in a 
FACS LSRII flow cytometer (BD Biosciences) and analyzed using the Flow-Jo software (Tree Star Inc.) The per-
centage of Env-positive cells and the Mean Fluorescence Intensity (MFI) of these cells were used to evaluate Env 
expression.
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To test fusion activity, 1 × 104 Env/Tat-transfected or control Tat-transfected HEK-293T cells were mixed 
(ratio 1:1) in 96-well plates with CD4+CXCR4+CCR5+ TZM-bl reporter cells for 6 hours. Luciferase activity was 
measured (Fluoroskan Accent, Labsystems) using Brite-Lite (PerkinElmer) and normalized to Bal-Env-mediated 
fusion as described9,47. NL4.3- and BaL-Env expression plasmids were used as positive controls for Env staining 
and as reference value for fusion activity (BaL = 100%).
Production of pseudoviruses. Replication-deficient luciferase-reporter pseudoviruses were obtained as 
described5,21,22, using the luciferase-expressing reporter virus HIV/Δnef/Δenv/luc (pNL4-3.Luc.R-E- provirus, 
lacking Env expression and bearing the luciferase gene inserted into the nef open reading frame; Catalog No. 
6070013, NIH AIDS Reagent Program) and the above-described env expression plasmids (isolated or refer-
ence Env). Viral stocks were normalized by p24 content measured by ELISA (Lenti-X™ p24 Rapid Titer Kit, 
Clontech, Saint-Germain-en-Laye, France). Alternatively, for infectivity analyses in TZM-bl cells, pseudoviruses 
were obtained by co-transfecting HEK-293T cells with the HIV-1 backbone-coding plasmid PSG3 (NIH AIDS 
Research and Reference Reagent Program) and the above-described env expression plasmids, isolated or refer-
ence Envs49. Titers were analyzed using standard methods50.
HIV-1 transfer/CD4 binding. To test viral transfer activity, which exclusively depends on the binding of 
gp120 to the CD4 molecule5, Env expression plasmids were co-transfected with the Env-defective pSG3 plasmid 
in HEK-293T cells. One day after transfection, 1 × 105 HEK-293T cells were mixed at a 1:1 ratio in 96-well plates 
with primary CD4+ T cells freshly isolated from healthy donors by negative selection (CD4+ T-Cell Isolation 
Kit II, human, Miltenyi Biotec)19,20. Viral transfer was assessed after 2 hours of incubation by staining cells with 
the anti-HIV-1 p24 Kc57 mAb (Coulter) as described45,51. Cells were acquired in a FACS LSRII flow cytometer 
and the content of p24 in gated CD4+ T cells and gated HEK-293T cells was analyzed using the Flow-Jo software 
(Tree Star Inc.). The percentage of p24+ HEK-293T cells was used as a control for transfection efficiency and was 
similar among all experiments. Since coreceptor binding or fusion activity are not required for viral transfer, the 
frequency of p24+/CD4+ T cells was a direct measure of the amounts of HIV-1 virions bound to or taken up by 
target cells.
Luciferase viral infection assay. CEM.NKR-CCR5 cells (9 × 105 cells in 24-well plates containing RPMI 
supplemented with 20 μg/mL of Polybrene) were infected with 500 ng of p24 of luciferase-reporter pseudoviruses, 
bearing VNP- or RP-Envs, in 1 mL total volume with RPMI 1640 for 2 hours (by centrifugation at 1,200 rpm at 
25 °C) and subsequent incubation for 4 hours at 37 °C, as previously described5,21,22. As a control for R5-tropic 
viral infection, a BaL.01-env plasmid (catalog number 11445, NIH AIDS Research and Reference Reagent 
Program) was used. Unbound virus was then removed by washing the infected cells. After 48 hours of infection, 
luciferase activity was measured using a luciferase assay kit (Biotium, Hayward, CA) with a microplate reader 
(VictorTM X5; PerkinElmer, Waltham, MA). When indicated, permissive cells were pretreated with an anti-CD4 
neutralizing mAb (5 μg/mL; eBioscience, San Diego, CA).
Signaling activity assays. For signaling activity assays, western blot analyses of HIV-1 Env-mediated 
α-tubulin acetylation were performed in CEM.NKR-CCR5 cells (1 × 106 cells) incubated with 500 ng of p24 of 
luciferase-reporter pseudoviruses for 90 minutes at 37 °C5,23, bearing VNP- or RP Envs. As indicated above, the 
R5-tropic BaL.01-env was used as a positive control. Membranes were first probed with anti-acetylated α-tubulin 
6-11B-1 mAb, then gently stripped (30 minutes at RT with stripping buffer: Glicine 7,5 g, SDS 0,5 g (w/v), Tween-20 
1% (v/v), pH 2,2 in 500 mL water; then 5 minutes at RT with washing buffer: NaCl 150 mM; and again membrane 
balance in Tris buffered saline Tween-20 buffer) and blotted with the anti-α-tubulin B-5-1-2 mAb (both from 
Sigma-Aldrich St. Louis, USA), and secondary antibodies conjugated with horseradish peroxidase (HRP, Dako, 
Glostrup, Denmark) were used to detect key bands on blots. The level of α-tubulin acetylation was quantified and 
expressed as the ratio of the intensities of the acetylated α-tubulin to the total α-tubulin bands, as described5,23.
Autophagy assays. The ability of Env clones to induce autophagy in CD4+ T cells was assessed by 
co-culturing for 2 days HEK-293T cells transiently expressing Env (effector cells) with the target HUT78 T-cell 
line. Cell-surface Env expression was analyzed as described above. Autophagy was analyzed by immunofluores-
cence after endogenous LC3 staining. Cells were fixed in a 1:1 acetone/methanol mixture for 5 minutes at −20 °C. 
Cells were washed in PBS and incubated with the rabbit anti-LC3 antibody L7543 (1 µg/mL, Sigma Aldrich) for 
1 h, washed, and then incubated with Alexa Fluor® 488 goat anti-rabbit IgG (2000 × diluted, Life Technologies) 
for 30 minutes. After washing, nuclei were labeled with DAPI and cells were examined by epifluorescence using 
a Leica microscope as described35. The number of LC3 dots (green) per CD4+ T cell was counted. More than 100 
CD4+ T cells were analyzed by 2 independent investigators.
Genotypic analyses. Full-length Env clones were sequenced using Big DyeTM Terminator Cycle in an ABI 
Prism 3730 XL Sequencer (Applied Biosystem, Life Technologies) in the Genomic Unit of the CNM-ISCIII. 
Sequences were assembled using the SeqMan program (DNASTAR Inc, Madison, WI). The program Bioedit 
Sequence Aligment Editor (version 7.1.3.0) was used to align and manually edited the nucleotide sequences 
obtained. A mean of 8 clones per patient were sequenced. Maximum likelihood trees were constructed and phy-
logenetic confidence was assessed by bootstrap analysis of 1,000 replicates using MEGA (Version 6.0) program. 
To estimate viral heterogeneity, we determined the mean pairwise nucleotide distances, and the standard error, 
between all sequences obtained for each patient. The genetic distance of each clone to the patient consensus 
sequence was also estimated by the best-fit model of nucleotide substitution.
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Statistics. Statistical analyses were performed using GraphPad Prism, version 5.0b (GraphPad Software) and 
R package version 3.5.2. Significance when comparing groups was determined with a 2-tailed nonparametric 
Mann Whitney U test or by non-parametric Kruskal-Wallis test with Dunn’s correction for multiple comparisons. 
Non-parametric Spearman test was used to calculate correlations. Association between parameters was analyzed 
taking into account repeated measures from different Env of each individual by fitting linear mixed effect models 
with random intercepts. The proportion of variance explained by the fixed predictors (R2) was calculated using 
the Nakagawa and Schielzeth’s approach52.
Statement. We confirm that all methods were carried out in accordance with relevant guidelines and regu-
lations. All procedures followed the Helsinki Declaration in 1975, as revised in 1983, and were approved by the 
Ethics committee of the Hospital Germans Trias I Pujol. All individuals provided their written informed consent.
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